Physical Activity in Reducing Functional Health Disparities in Older Stage I-III Breast Cancer Survivors
- Pathologically confirmed breast cancer
- Stage I-III
- Patients who have completed treatment but are within five years of treatment completion (primary surgery, chemotherapy or radiation therapy), whichever was received last; hormonal therapy and targeted therapy are allowed
- Race: African-Americans and non-Hispanic whites
- Stage IV breast cancer
- Patients with end-stage disease, severe dementia and/or life expectancy of less than one year
- Inability to understand English
- Inability to provide informed consent
- High-risk patients (as defined by the American College of Sports Medicine risk-stratification schema using the American College of Sports Medicine [ACSM]/American Heart Association exercise pre-participation questionnaire) who do not receive medical clearance from a physician
- Other medical or psychological conditions that would make participation unsafe or inhibit our ability to test our primary hypothesis, e.g. Parkinson’s disease, severe dementia
I. To determine the effect of a refined and culturally-sensitive physical activity intervention on functional outcomes at 20 and 52 weeks among older breast cancer (BCa) survivors who are within five years of treatment completion for stage I-III BCa.
II. To examine whether race and socio-economic status (SES) moderate the intervention effect on physical activity (PA) levels and functional outcomes at 20 and 52 weeks
III. To examine the effect of the PA intervention on longitudinal changes in beliefs, attitudes, preferences (KAPs) and PA levels, and the extent to which changes in these factors mediate intervention effect on functional outcomes.
IV. To determine the effect of the PA intervention on surrogate biomarkers associated with breast cancer prognosis and functional disability.
OUTLINE: Patients are randomized into 1 of 2 groups.
GROUP I: Patients undergo supervised aerobic exercise over 40 minutes and resistance training over 20 minutes 3 times per week for 20 weeks. Patients then participate in regular exercise sessions on flexible schedule for 32 weeks.
GROUP II: Patients participate in structured health education and support group sessions over 60 minutes once per week for 20 weeks. Patients then participate in support group sessions for 32 weeks.
Trial Phase Phase III
Trial Type Supportive care
Case Comprehensive Cancer Center
- Primary ID CASE2116
- Secondary IDs NCI-2016-01773
- Clinicaltrials.gov ID NCT02763228